FTC investigating Johnson & Johnson's Remicade contracting practices
July 30, 2019 at 12:22 PM EDT
Pfizer sued Johnson & Johnson in 2017 alleging the company was engaged in anticompetitive tactics to slow sales of biosimilars.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|